Human Mass Balance and Metabolite Profiling of [C-14]-Pamiparib, a Poly (ADP-Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer

Mu, S; Palmer, D; Fitzgerald, R; Andreu-Vieyra, C; Zhang, H; Tang, ZY; Su, D; Sahasranaman, S

Sahasranaman, S (corresponding author), BeiGene USA Inc, 2955 Campus Dr, San Mateo, CA 94403 USA.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021; 10 (9): 1108

Abstract

Pamiparib, a selective poly (ADP-ribose) polymerase 1/2 inhibitor, demonstrated tolerability and antitumor activity in patients with solid tumors at 6......

Full Text Link